baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AES Corp/ US00130H1059 /

2024-07-24 10:10:00 PM	Chg. -0.25	Volume	Bid10:22:12 AM	Ask10:22:12 AM	Market Capitalization	Dividend Y.	P/E Ratio
17.31USD	-1.42%	10.05 mill. Turnover: 141 mill.	17.16Bid Size: 200	17.79Ask Size: 200	12.3 bill.USD	3.87%	46.78

Newsfile Corp 07-17 Appia Announces Excellent Desorption Results From Target IV Ionic Adsorption Clay Rare Earth Mineral...

Newsfile Corp 07-08 NorthX Nickel Provides Exploration Update on the Grasset Nickel Project

GlobeNewswire 07-01 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...

GlobeNewswire 06-27 Brand Trust Is Higher for Utilities That Spend More on Communication and Highlight Savings and Envir...

GlobeNewswire 06-27 Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a N...

GlobeNewswire 06-27 Lantronix Launches New EDS5000 Series Device Server

GlobeNewswire 06-26 AMERICAN SALARS SUBMITS SAMPLES FOR ASSAY FROM THE NEVADA BLACK ROCK SOUTH LITHIUM BRINE PROJECT

GlobeNewswire 06-25 Exploration Drilling at Becher Project Recommences

GlobeNewswire 06-25 Tsecond and Carahsoft Partner to Bring Low SWaP, High-Performance Data Solutions for AI, Analytics a...

GlobeNewswire 06-25 Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Tri...

GlobeNewswire 06-24 InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel ...

GlobeNewswire 06-21 Neon Bloom Completes Acquisition of Advanced Executive Sales, LLC

GlobeNewswire 06-20 Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...

GlobeNewswire 06-20 Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for...

GlobeNewswire 06-20 Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potentia...

GlobeNewswire 06-18 XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treat...

GlobeNewswire 06-18 Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low ...

GlobeNewswire 06-17 2024 CSO Award Winners and Hall of Fame Inductees to be Recognized at the CSO Conference & Awards

GlobeNewswire 06-17 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...

GlobeNewswire 06-14 Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...

GlobeNewswire 06-14 Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...

GlobeNewswire 06-13 Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway

GlobeNewswire 06-12 NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at ...

GlobeNewswire 06-12 Hickcoin Exchange Releases Latest Security Report, Demonstrating Robust Protection Capabilities

GlobeNewswire 06-12 NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa T...

AES Corp/ US00130H1059 /

If you wish to receive reply to your feedback, please provide your email address.